Treatment of refractory oral erosive lichen planus with topical rapamycin: 7 Cases

Dermatology

Volumn 218, Issue 1, 2008, Pages 22-25

  Soria, A ^a   Agbo Godeau, S ^b   Taieb A ^c   Frances C ^a  

^a HÔPITAL TENON   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c HÔPITAL SAINT ANDRÉ   (France)

Author keywords

Erosive lichen planus; Topical rapamycin

Indexed keywords

RAPAMYCIN;

ADULT; AGED; ANUS; APPLICATION SITE BURNING; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE DURATION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; HUMAN; LICHEN PLANUS; MOUTH MUCOSA; OPEN STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REMISSION; SKIN TINGLING; TREATMENT DURATION;

ADMINISTRATION, CUTANEOUS; AGED; ANTINEOPLASTIC AGENTS; BIOPSY; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LICHEN PLANUS, ORAL; MIDDLE AGED; PROSPECTIVE STUDIES; SIROLIMUS; TREATMENT OUTCOME; VULVAR LICHEN SCLEROSUS;

EID: 58149094346     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000172830     Document Type: Article

References (16)

1. Eisen D: The therapy of oral lichen planus. Crit Rev Oral Biol Med 1993;4:141-158.
2. Gandolfo S, Richiardi L, Carrozzo M, et al: Risk of oral squamous cell carcinoma in 402 patients with oral lichen planus: a follow-up study in an Italian population. Oral Oncol 2004;40:77-83.
3. Holt DW, Lee T, Johnston A: Measurement of sirolimus in whole blood using high-performance liquid chromatography with ultraviolet detection. Clin Ther 2000;22(suppl B):B38-B48.
4. Kaliakatsou F, Hodgson TA, Lewsey JD, et al: Management of recalcitrant ulcerative oral lichen planus with topical tacrolimus. J Am Acad Dermatol 2002;46:35-41.
5. Byrd JA, Davis MD, Bruce AJ, et al: Response of oral lichen planus to topical tacrolimus in 37 patients. Arch Dermatol 2004;140:1508-1512 (erratum published in Arch Dermatol 2005;141:370).
6. Laeijendecker R, Tank B, Dekker SK, et al: A comparison of treatment of oral lichen planus with topical tacrolimus and triamcinolone acetonide ointment. Acta Derm Venereol 2006;86:227-229.
7. Conrotto D, Carbone M, Carrozzo M, et al: Cyclosporin vs clobetasol in the topical management of atrophic and erosive oral lichen planus: a double-blind, randomized controlled trial. Br J Dermatol 2006;154:139-145.
8. Thongprasom K, Chaimusig M, Korkij W, et al: A randomized-controlled trial to compare topical cyclosporin with triamcinolone acetonide for the treatment of oral lichen planus. J Oral Pathol Med 2007;36:142-146.
9. Guba M, Graeb C, Jauch KW, et al: Pro- and anti-cancer effects of immunosuppressive agents used in organ transplantation. Transplantation 2004;77:1777-1782.
10. Weischer M, Röcken M, Berneburg M: Calcineurin inhibitors and rapamycin: cancer protection or promotion? Exp Dermatol 2007;16:385-393.
11. Mahé E, Morelon E, Lechaton S, Kreis H, de Prost Y, Bodemer C: Angioedema in renal transplant recipients on sirolimus. Dermatology 2007;214:205-209.
12. MacDonald AS, Rapamune Global Study Group: A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts. Transplantation 2001;71:271-280.
13. Vasudev B, Hariharan S: Cancer after renal transplantation. Curr Opin Nephrol Hypertens 2007;16:523-528.
14. Gonwa T, Mendez R, Yang HC, Weinstein S, Jensik S, Steinberg S, Prograf Study Group: Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months. Transplantation 2003;75:1213-1220.
15. Mahé E, Morelon E, Lechaton S, Sang KH, Mansouri R, Ducasse MF, Mamzer-Bruneel MF, de Prost Y, Kreis H, Bodemer C: Cutaneous adverse events in renal transplant recipients receiving sirolimus-based therapy. Transplantation 2005;79:476-482.
16. Choonhakarn C, Busaracome P, Sripanidkulchai B, Sarakarn P: The efficacy of aloe vera gel in the treatment of oral lichen planus: a randomized controlled trial. Br J Dermatol 2008;158:573-577.